FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056198101> ?p ?o ?g. }

• W2056198101 endingPage "S12" @default.
• W2056198101 startingPage "S6" @default.
• W2056198101 abstract "Experimental and clinical studies indicate that both dopamine D2-like and D1-like receptors are important in reversing the motor symptoms of Parkinson's disease, and therefore stimulation of both D1 and D2 receptors may be advantageous in its treatment. At present, the role of other receptor subtypes, such as the D3 receptor, remains unknown, although in primates the D3 receptor might be of importance because it exists in significant amounts within the caudate-putamen. Both D1 and D2 agonists induce dyskinesias in drug-naive, MPTP-treated primates and provoke dyskinesias in levodopa-primed animals. D1 agonists in low doses, however, might have antiparkinsonian effects without inducing dyskinesias, and on repeated administration perhaps can diminish the intensity of dyskinesias in levodopa-primed, MPTP-treated primates. The production of dyskinesias in Parkinson's disease might reflect an imbalance in the D1-direct and D2-indirect GABAergic output pathways from the caudate-putamen, which colocalize tachykinins and enkephalins, respectively. Destruction of the nigrostriatal pathway decreases the mRNA for substance P but elevates the mRNA for enkephalin. Treatment with levodopa reverses the decrease in substance P mRNA but has either a partial or no effect on mRNA for enkephalin. This suggests that levodopa treatment leads to a new imbalance between output from the striatum through the direct and indirect pathways. In contrast, dopamine agonists appear less able than levodopa to manipulate basal ganglia outflow. This might reflect their decreased ability to reverse parkinsonian motor deficits or the greater ability of levodopa to provoke dyskinesias. Dopamine agonist drugs also might exert neuroprotective actions.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
• W2056198101 created "2016-06-24" @default.
• W2056198101 creator A5030909442 @default.
• W2056198101 date "1995-03-01" @default.
• W2056198101 modified "2023-10-16" @default.
• W2056198101 title "The rationale for the use of dopamine agonists in Parkinson's disease" @default.
• W2056198101 cites W1978598997 @default.
• W2056198101 cites W2046064727 @default.
• W2056198101 cites W2047028663 @default.
• W2056198101 cites W2075004169 @default.
• W2056198101 cites W2075577390 @default.
• W2056198101 cites W2081963528 @default.
• W2056198101 cites W2157443081 @default.
• W2056198101 cites W2163131045 @default.
• W2056198101 cites W2316080658 @default.
• W2056198101 cites W2325211721 @default.
• W2056198101 doi "https://doi.org/10.1212/wnl.45.3_suppl_3.s6" @default.
• W2056198101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7715795" @default.
• W2056198101 hasPublicationYear "1995" @default.
• W2056198101 type Work @default.
• W2056198101 sameAs 2056198101 @default.
• W2056198101 citedByCount "101" @default.
• W2056198101 countsByYear W20561981012012 @default.
• W2056198101 countsByYear W20561981012013 @default.
• W2056198101 countsByYear W20561981012014 @default.
• W2056198101 countsByYear W20561981012015 @default.
• W2056198101 countsByYear W20561981012016 @default.
• W2056198101 countsByYear W20561981012017 @default.
• W2056198101 countsByYear W20561981012018 @default.
• W2056198101 countsByYear W20561981012019 @default.
• W2056198101 countsByYear W20561981012022 @default.
• W2056198101 countsByYear W20561981012023 @default.
• W2056198101 crossrefType "journal-article" @default.
• W2056198101 hasAuthorship W2056198101A5030909442 @default.
• W2056198101 hasConcept C120069818 @default.
• W2056198101 hasConcept C120750228 @default.
• W2056198101 hasConcept C126322002 @default.
• W2056198101 hasConcept C134018914 @default.
• W2056198101 hasConcept C137183658 @default.
• W2056198101 hasConcept C15744967 @default.
• W2056198101 hasConcept C169760540 @default.
• W2056198101 hasConcept C170493617 @default.
• W2056198101 hasConcept C199596767 @default.
• W2056198101 hasConcept C2777803847 @default.
• W2056198101 hasConcept C2778187257 @default.
• W2056198101 hasConcept C2778674702 @default.
• W2056198101 hasConcept C2778938600 @default.
• W2056198101 hasConcept C2779134260 @default.
• W2056198101 hasConcept C2779714222 @default.
• W2056198101 hasConcept C2779734285 @default.
• W2056198101 hasConcept C2780062018 @default.
• W2056198101 hasConcept C2780304432 @default.
• W2056198101 hasConcept C2780405171 @default.
• W2056198101 hasConcept C2781063702 @default.
• W2056198101 hasConcept C2781423529 @default.
• W2056198101 hasConcept C44208683 @default.
• W2056198101 hasConcept C513476851 @default.
• W2056198101 hasConcept C529278444 @default.
• W2056198101 hasConcept C71924100 @default.
• W2056198101 hasConceptScore W2056198101C120069818 @default.
• W2056198101 hasConceptScore W2056198101C120750228 @default.
• W2056198101 hasConceptScore W2056198101C126322002 @default.
• W2056198101 hasConceptScore W2056198101C134018914 @default.
• W2056198101 hasConceptScore W2056198101C137183658 @default.
• W2056198101 hasConceptScore W2056198101C15744967 @default.
• W2056198101 hasConceptScore W2056198101C169760540 @default.
• W2056198101 hasConceptScore W2056198101C170493617 @default.
• W2056198101 hasConceptScore W2056198101C199596767 @default.
• W2056198101 hasConceptScore W2056198101C2777803847 @default.
• W2056198101 hasConceptScore W2056198101C2778187257 @default.
• W2056198101 hasConceptScore W2056198101C2778674702 @default.
• W2056198101 hasConceptScore W2056198101C2778938600 @default.
• W2056198101 hasConceptScore W2056198101C2779134260 @default.
• W2056198101 hasConceptScore W2056198101C2779714222 @default.
• W2056198101 hasConceptScore W2056198101C2779734285 @default.
• W2056198101 hasConceptScore W2056198101C2780062018 @default.
• W2056198101 hasConceptScore W2056198101C2780304432 @default.
• W2056198101 hasConceptScore W2056198101C2780405171 @default.
• W2056198101 hasConceptScore W2056198101C2781063702 @default.
• W2056198101 hasConceptScore W2056198101C2781423529 @default.
• W2056198101 hasConceptScore W2056198101C44208683 @default.
• W2056198101 hasConceptScore W2056198101C513476851 @default.
• W2056198101 hasConceptScore W2056198101C529278444 @default.
• W2056198101 hasConceptScore W2056198101C71924100 @default.
• W2056198101 hasIssue "Issue 3, Supplement 3" @default.
• W2056198101 hasLocation W20561981011 @default.
• W2056198101 hasLocation W20561981012 @default.
• W2056198101 hasOpenAccess W2056198101 @default.
• W2056198101 hasPrimaryLocation W20561981011 @default.
• W2056198101 hasRelatedWork W1979792701 @default.
• W2056198101 hasRelatedWork W2013129024 @default.
• W2056198101 hasRelatedWork W2056198101 @default.
• W2056198101 hasRelatedWork W2077987075 @default.
• W2056198101 hasRelatedWork W2085955635 @default.
• W2056198101 hasRelatedWork W2101392799 @default.
• W2056198101 hasRelatedWork W2414276518 @default.
• W2056198101 hasRelatedWork W2416071970 @default.
• W2056198101 hasRelatedWork W2419341280 @default.

• next